Evidence map›Paper›PMID 38022597›Full record

ArticleFrontiers in immunology2023

Editorial: Interferons: key modulators of the immune system in cancer.

Nabiha Yusuf, S Rameeza Allie, Bryan E Strauss

Open access · goldAbstract readEditorial
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Nabiha YusufDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL, United States.
S Rameeza AllieDepartment of Microbiology and Immunology, Penn State College of Medicine, Hershey, PA, United States.
Bryan E StraussInstitute of Cancer of São Paulo, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
Penn State Milton S. Hershey Medical Center · USUniversidade de São Paulo · BRUniversity of Alabama at Birmingham · US

Funding

Mechanisms elicited by type I interferons in cutaneous photocarcinogenesisR01AR071157 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI YUSUF, NABIHA · 2016 to 2020
$1.8M
NIAMS NIH HHS R01 AR071157
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

InterferonsNeoplasmsHumansImmune SystemInterferon-gammaInterferon-gammaInterferonscancerimmune systemimmunotherapyinterferonregulation

Identifiers

PMID38022597
PMCPMC10663290
OpenAlexW4388523551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.